Stocks News

LAST PRICE
25.8600
TODAY'S CHANGE (%)
Trending Up1.5000 (6.1576%)

Bid / Lots
25.5200/ 3
Ask / Lots
25.6000/ 4
Open / Previous Close
24.4900 / 24.3600
Day Range
Low 23.6000
High 26.0200
52 Week Range
Low 9.8100
High 26.9900
Volume
3,953,632
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- DJ TG Therapeutics Is Maintained at Buy by HC Wainwright & Co., from 4 hours ago by Dow Jones
  4 hours ago by Dow Jones
  Companies Mentioned: TGTX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/TGTX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 05, 2024 12:51 ET (17:51 GMT)
- DJ TG Therapeutics Is Maintained at Neutral by Goldman Sachs, from 5 hours ago by Dow Jones
  5 hours ago by Dow Jones
  Companies Mentioned: TGTX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/TGTX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 05, 2024 12:36 ET (17:36 GMT)
Yesterday
- Sector Update: Health Care Stocks Mixed Premarket Monday, from 9:08AM ET on Monday Nov 04, 2024 by MT Newswires
  9:08AM ET on Monday Nov 04, 2024 by MT Newswires
  Companies Mentioned: IBB, TGTX, XLV, ZTS, BNTX
  09:08 AM EST, 11/04/2024 (MT Newswires) -- Health care stocks were mixed premarket Monday as the iShares Biotechnology ETF (IBB) was 0.1% higher and the Health Care Select Sector SPDR Fund (XLV) was down 0.1% recently. Zoetis (ZTS) shares advanced b...
- TG Therapeutics Q3 Earnings, Revenue Fall, from 7:37AM ET on Monday Nov 04, 2024 by MT Newswires
  7:37AM ET on Monday Nov 04, 2024 by MT Newswires
  Companies Mentioned: TGTX
  07:37 AM EST, 11/04/2024 (MT Newswires) -- TG Therapeutics (TGTX) reported Q3 earnings Monday of $0.02 per diluted share, down from $0.73 a year earlier. Analysts polled by Capital IQ expected $0.03. Revenue for the quarter ended Sept. 30 was $83.9 ...
- -- Earnings Flash (TGTX) TG THERAPEUTICS Posts Q3 Revenue $83.9M, from 7:03AM ET on Monday Nov 04, 2024 by MT Newswires
  7:03AM ET on Monday Nov 04, 2024 by MT Newswires
  Companies Mentioned: TGTX
  07:03 AM EST, 11/04/2024 (MT Newswires) -- ...

Today
- Kirby McInerney LLP Announces Investigation of Shareholder Claims Against ADMA Biologics, Inc. (ADMA), from 1 hour ago by Dow Jones
  1 hour ago by Dow Jones
  Companies Mentioned: ADMA
- ADMA STOCK NEWS: ADMA Biologics is Under Investigation for Securities Fraud after Stock Dropped 20%; Contact BFA Law if You Suffered Losses (Nasdaq:ADMA), from 1 hour ago by Dow Jones
  1 hour ago by Dow Jones
  Companies Mentioned: ADMA
- ADMA Investors Have Opportunity to Join ADMA Biologics, Inc. Fraud Investigation with the Schall Law Firm, from 7 hours ago by Dow Jones
  7 hours ago by Dow Jones
  Companies Mentioned: ADMA
- ADMA INQUIRY ALERT: BFA Law Announces ADMA Biologics is being Investigated for Securities Fraud and Urges Investors to Contact the Firm, from 10 hours ago by Newsfile
  10 hours ago by Newsfile
  Companies Mentioned: ADMA
- ADMA INQUIRY ALERT: BFA Law Announces ADMA Biologics is being Investigated for Securities Fraud and Urges Investors to Contact the Firm, from 10 hours ago by Dow Jones
  10 hours ago by Dow Jones
  Companies Mentioned: ADMA
Yesterday
- Did ADMA Biologics Commit Securities Fraud Resulting in 20% Stock Drop? Contact BFA Law about its Ongoing Securities Fraud Investigation (Nasdaq:ADMA), from 3:36PM ET on Monday Nov 04, 2024 by Dow Jones
  3:36PM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: ADMA
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 3:30PM ET on Monday Nov 04, 2024 by Dow Jones
  3:30PM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: ADMA
- ADMA INQUIRY ALERT: A Securities Fraud Investigation has been Initiated against ADMA Biologics into the Auditor Resignation; Investors with Losses are Urged to Contact the Firm (Nasdaq:ADMA), from 6:38AM ET on Monday Nov 04, 2024 by Dow Jones
  6:38AM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: ADMA
Nov 3, 2024
- BFA Law Announces ADMA BIOLOGICS Is Being Investigated for Securities Fraud After Auditor Resigned and Urges Investors Who Lost Money to Contact the Firm, from 8:34AM ET on Sunday Nov 03, 2024 by Newsfile
  8:34AM ET on Sunday Nov 03, 2024 by Newsfile
  Companies Mentioned: ADMA
- BFA Law Announces ADMA BIOLOGICS Is Being Investigated for Securities Fraud After Auditor Resigned and Urges Investors Who Lost Money to Contact the Firm, from 8:34AM ET on Sunday Nov 03, 2024 by Dow Jones
  8:34AM ET on Sunday Nov 03, 2024 by Dow Jones
  Companies Mentioned: ADMA

TG Therapeutics Inc
NASDAQ:TGTXUnited States

Search Criteria

Today

DJ TG Therapeutics Is Maintained at Buy by HC Wainwright & Co., from 4 hours ago by Dow Jones

DJ TG Therapeutics Is Maintained at Neutral by Goldman Sachs, from 5 hours ago by Dow Jones

Yesterday

Sector Update: Health Care Stocks Mixed Premarket Monday, from 9:08AM ET on Monday Nov 04, 2024 by MT Newswires

TG Therapeutics Q3 Earnings, Revenue Fall, from 7:37AM ET on Monday Nov 04, 2024 by MT Newswires

-- Earnings Flash (TGTX) TG THERAPEUTICS Posts Q3 Revenue $83.9M, from 7:03AM ET on Monday Nov 04, 2024 by MT Newswires

Peers Headlines

Today

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against ADMA Biologics, Inc. (ADMA), from 1 hour ago by Dow Jones

ADMA STOCK NEWS: ADMA Biologics is Under Investigation for Securities Fraud after Stock Dropped 20%; Contact BFA Law if You Suffered Losses (Nasdaq:ADMA), from 1 hour ago by Dow Jones

ADMA Investors Have Opportunity to Join ADMA Biologics, Inc. Fraud Investigation with the Schall Law Firm, from 7 hours ago by Dow Jones

ADMA INQUIRY ALERT: BFA Law Announces ADMA Biologics is being Investigated for Securities Fraud and Urges Investors to Contact the Firm, from 10 hours ago by Newsfile

ADMA INQUIRY ALERT: BFA Law Announces ADMA Biologics is being Investigated for Securities Fraud and Urges Investors to Contact the Firm, from 10 hours ago by Dow Jones

Yesterday

Did ADMA Biologics Commit Securities Fraud Resulting in 20% Stock Drop? Contact BFA Law about its Ongoing Securities Fraud Investigation (Nasdaq:ADMA), from 3:36PM ET on Monday Nov 04, 2024 by Dow Jones

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 3:30PM ET on Monday Nov 04, 2024 by Dow Jones

ADMA INQUIRY ALERT: A Securities Fraud Investigation has been Initiated against ADMA Biologics into the Auditor Resignation; Investors with Losses are Urged to Contact the Firm (Nasdaq:ADMA), from 6:38AM ET on Monday Nov 04, 2024 by Dow Jones

Nov 3, 2024

BFA Law Announces ADMA BIOLOGICS Is Being Investigated for Securities Fraud After Auditor Resigned and Urges Investors Who Lost Money to Contact the Firm, from 8:34AM ET on Sunday Nov 03, 2024 by Newsfile

BFA Law Announces ADMA BIOLOGICS Is Being Investigated for Securities Fraud After Auditor Resigned and Urges Investors Who Lost Money to Contact the Firm, from 8:34AM ET on Sunday Nov 03, 2024 by Dow Jones